Showing results (141-150 of 169) with videos related to

Sort By:
Pageof 17
Cell Reports|October 23, 2021
NKG2A expression identifies a subset of human Vδ2 T cells exerting the highest antitumor effector functionsValentina Cazzetta, Elena Bruni, Sara Terzoli, et al.
EMBO Molecular Medicine|January 21, 2021
Modeling, optimization, and comparable efficacy of T cell and hematopoietic stem cell gene editing for treating hyper-IgM syndromeValentina Vavassori, Elisabetta Mercuri, Genni E Marcovecchio, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 25, 2012
RANK-dependent autosomal recessive osteopetrosis: characterization of five new cases with novel mutationsAlessandra Pangrazio, Barbara Cassani, Matteo M Guerrini, et al.
American Journal of Human Genetics|July 9, 2008
Human osteoclast-poor osteopetrosis with hypogammaglobulinemia due to TNFRSF11A (RANK) mutationsMatteo M Guerrini, Cristina Sobacchi, Barbara Cassani, et al.
Cell Reports. Medicine|November 13, 2024
A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cellsLucrezia Della Volpe, Federico Midena, Roberta Vacca, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 29, 2012
Preclinical safety and efficacy of human CD34(+) cells transduced with lentiviral vector for the treatment of Wiskott-Aldrich syndromeSamantha Scaramuzza, Luca Biasco, Anna Ripamonti, et al.
Nature Cell Biology|April 9, 2024
CD32 captures committed haemogenic endothelial cells during human embryonic developmentRebecca Scarfò, Lauren N Randolph, Monah Abou Alezz, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 3, 2013
SNX10 mutations define a subgroup of human autosomal recessive osteopetrosis with variable clinical severityAlessandra Pangrazio, Anders Fasth, Andrea Sbardellati, et al.
The Journal of Allergy and Clinical Immunology|March 31, 2019
Lentiviral gene therapy corrects platelet phenotype and function in patients with Wiskott-Aldrich syndromeLucia Sereni, Maria Carmina Castiello, Dario Di Silvestre, et al.
Pageof 17